Skip to main content
Caplight Logo









Orixha

Orixha

Private
Maisons-AlfortHealthcare & Life Scienceshttps://orixha.com/

Last Round

Grant

May 20, 2025

Total Funding Raised

$16.17M

Company Overview

Orixha is a medical technology company that develops a proprietary total liquid ventilation technology to improve clinical outcomes for critical care patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

total liquid ventilationTLVtherapeutic hypothermiacritical care medical devicecardiac arrest treatmentmedical techmedtechrespiratory supportorgan protectionrazor and blade modelconsumable medical suppliesdeeptech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orixha Comparables

Compare Orixha with similar companies based on industry and business-model similarity.

Orixha comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EM-MED Sp. z o.o. Sp. K.
79%
BrainCool AB
78%
Life Recovery Systems
76%

Orixha Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 20, 2025
SeedApr 10, 2024
GrantOct 1, 2022
SeedDec 10, 2021
GrantJun 2, 2020

Key People

Founding team and executive leadership

Mathieu Nadeau

CTO & Co-Founder

Founding Team

Renaud Tissier

Co-founder - Acting CMO

Founding Team

Fabrice PAUBLANT

CEO co-founder

Founding Team

Orixha Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 86% MoM, reaching 1.4K.

  • Feb 3, 2026

    Grew 40% QoQ from 10 to 14 employees.

Orixha Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orixha Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orixha's valuation, stock price, and market status.

Firmographic Details

HeadquartersMaisons-Alfort
Employee Range14
Year Founded2018
Last FundingMay 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?